A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

Recruiting

Phase 2

IPN10200A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

Sponsor:

Ipsen

Code:

NCT06625060

Conditions

Episodic Migraine

Chronic Migraine

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Corabotase

Placebo

Corabotase dose A

Corabotase dose B

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-30. This information was provided to ClinicalTrials.gov by Ipsen on 2026-07-28.